Fictor Alimentos S.A.

What it is

Fictor Alimentos S.A. is the result of a strategic restructuring of the former Atom Empreendimentos e Participações (ticker ATOM3), after Fictor Holding and AQWA Capital took control of the listed company through a reverse IPO, acquiring approximately 76% of shares in November 2024. In a reverse IPO, a private company buys a firm that is already listed on the stock exchange — skipping the lengthy process of a traditional listing — and repurposes it with a new business plan.

The company now focuses on the strategic management of a portfolio in the animal protein sector, with its primary purpose being to increase value and operational efficiency, specifically targeting the recovery of distressed assets. Think of it as a turnaround fund wearing a food-company hat: it seeks struggling slaughterhouses, buys them cheaply inside insolvency proceedings, and tries to restore them to health.

Who owns it

Fictor Holding and AQWA Capital took control, acquiring approximately 76% of shares in November 2024. The EODHD data shows insiders collectively hold 87.2% of shares, leaving a free float of roughly 12.8% — (our calculation) — meaning the public market in this stock is very thin.

The predecessor company, Atompar, belonged to founders Carol Paiffer and Joaquim Paiffer, along with Exame magazine, before Grupo Fictor and AQWA acquired control. Influencer Carol Paiffer, one of the founders of Atom and a well-known figure in Brazil’s financial market, left the company after the sale of the controlling stake.

Who runs it

Rafael Ribeiro Leite de Góis serves as Chairman of the Board of Directors and Acting CEO, with Raul Alves Araujo do Nascimento as Chief Financial Officer and André Luiz Carneiro de Vasconcellos as Director of Strategy, Planning and Investor Relations.

The CEO and chairman role is held by Góis, the group’s co-founder. Fictor Alimentos is part of Grupo Fictor, a multi-sector group operating primarily in food industry, financial services, and infrastructure.

The money, in plain words

The numbers are raw. In 2022 — before the restructuring — the old Atom entity booked R$35.9m (≈US$7.0m) in revenue and a net profit of R$10.0m (≈US$1.9m), a net profit margin of 27.9% (our calculation).

By 2023, sales had fallen by 40.8% (our calculation) to R$21.2m (≈US$4.1m) and the company slipped to a net loss of R$515,000 (≈US$100,000). The 2024 annual filing shows zero reported revenue as the company sat largely pre-operational during its ownership change, burning R$1.4m (≈US$272,000) in losses.

The balance sheet is the starkest warning: the transaction that brought in the new owners was worth R$20m (US$4 mn). Yet total assets at year-end 2024 were just R$1,000 (≈US$194) against R$8.5m (≈US$1.65m) in liabilities — leaving stockholders’ equity at negative R$8.5m (≈–US$1.65m) (our calculation).

A negative equity means the company technically owes more than it owns; the new owners have their rebuilding work cut out for them.

What it is doing now

Fictor Alimentos announced the acquisition of a production unit from Mellore Alimentos Ltda., located in Betim, Minas Gerais, for R$30.4m (≈US$5.9m). This is the company’s first deal since listing, and it was bought from inside Mellore’s insolvency proceedings — the distressed-asset playbook in action.

The plant holds SIF federal inspection certification, which authorises it to produce, sell, and export animal-origin food products in Brazil.

Fictor Alimentos plans further acquisitions through 2025, with management stating it is looking at poultry, fish, and seafood companies. The company is also preparing an investment of R$150m (≈US$29.1m) in an expanded production facility in Betim.

What to watch

• Revenue actually arriving. The Betim plant only began operations in late 2025; results reflecting the start of operations were disclosed in November 2025. Whether those operations can generate enough cash to cover the company’s liabilities is the first test.
• Solvency. Negative equity of R$8.5m (≈US$1.65m) and zero reported cash at year-end 2024 mean the company depends entirely on shareholder injections to fund its acquisition pipeline. The company already has authorization for a capital increase, with contributions from shareholders to drive its acquisition movement.
• Deal execution. The company’s focus is precisely the purchase of firms in insolvency or bankruptcy; “the core of the company is to look for stressed assets,” management says. Buying distressed businesses cheaply is a real skill — whether this team has it remains unproven at scale.
• Liquidity risk. With insiders holding ~87% and a market cap of roughly US$2m, this is one of Brazil’s smallest listed companies. The free float is so thin that share prices can move sharply on very little trading volume.

This is news, not investment advice.